Dolby Laboratories Stock Plummets to New 52-Week Low at $64.23

Dolby Laboratories, Inc. has reached a new 52-week low, trading at USD 64.23 on November 17, 2025. This marks a significant decline for the small-cap software company, which has seen its stock price decrease by 18.4% over the past year, contrasting sharply with the S&P 500's performance of 13.19% during the same period.
The company's market capitalization stands at USD 7,024 million, with a price-to-earnings (P/E) ratio of 27.00. Despite a dividend yield of 1.80%, Dolby's financial metrics indicate challenges, including a low return on equity of 10.42% and a price-to-book ratio of 2.70. The firm has reported a decline in pre-tax profit and net profit, with respective drops of 33.05% and 31.39% in the latest quarter.

Dolby Laboratories has also experienced stagnant growth, with net sales increasing at an annual rate of just 2.52% over the last five years. The company's cash and equivalents have reached a low of USD 1,507.67 million, further highlighting its current financial position. With high institutional holdings at 100%, the stock's performance continues to be closely monitored by investors.